Literature DB >> 22743658

Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.

Michael C Kruer1, Reema Paudel, Wendy Wagoner, Lynn Sanford, Eleanna Kara, Allison Gregory, Tom Foltynie, Andrew Lees, Kailash Bhatia, John Hardy, Susan J Hayflick, Henry Houlden.   

Abstract

Several causative genes have been identified for both dystonia-parkinsonism and neurodegeneration with brain iron accumulation (NBIA), yet many patients do not have mutations in any of the known genes. Mutations in the ATP13A2 lead to Kufor Rakeb disease, a form of autosomal recessive juvenile parkinsonism that also features oromandibular dystonia. More recently, evidence of iron deposition in the caudate and putamen have been reported in patients with ATP13A2 mutations. We set out to determine the frequency of ATP13A2 mutations in cohorts of idiopathic NBIA and dystonia-parkinsonism. We screened for large deletions using whole genome arrays, and sequenced the entire coding region in 92 cases of NBIA and 76 cases of dystonia-parkinsonism. A number of coding and non-coding sequence variants were identified in a heterozygous state, but none were predicted to be pathogenic based on in silico analyses. Our results indicate that ATP13A2 mutations are a rare cause of both NBIA and dystonia-parkinsonism.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743658      PMCID: PMC3619445          DOI: 10.1016/j.neulet.2012.06.036

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype.

Authors:  Y P Ning; K Kanai; H Tomiyama; Y Li; M Funayama; H Yoshino; S Sato; M Asahina; S Kuwabara; A Takeda; T Hattori; Y Mizuno; N Hattori
Journal:  Neurology       Date:  2008-04-15       Impact factor: 9.910

2.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

Review 3.  Rare causes of dystonia parkinsonism.

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

4.  Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.

Authors:  Norbert Brüggemann; Johann Hagenah; Kathrin Reetz; Alexander Schmidt; Meike Kasten; Inga Buchmann; Susanne Eckerle; Manfred Bähre; Alexander Münchau; Ana Djarmati; Joyce van der Vegt; Hartwig Siebner; Ferdinand Binkofski; Alfredo Ramirez; Maria I Behrens; Christine Klein
Journal:  Arch Neurol       Date:  2010-11

5.  Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism.

Authors:  Laura A Engel; Zheng Jing; Daniel E O'Brien; Mengyang Sun; Paul T Kotzbauer
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

6.  Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome.

Authors:  A S Najim al-Din; A Wriekat; A Mubaidin; M Dasouki; M Hiari
Journal:  Acta Neurol Scand       Date:  1994-05       Impact factor: 3.209

7.  ATP13A2 variants in early-onset Parkinson's disease patients and controls.

Authors:  Ana Djarmati; Johann Hagenah; Kathrin Reetz; Susen Winkler; Maria Isabel Behrens; Heike Pawlack; Katja Lohmann; Alfredo Ramirez; Vera Tadić; Norbert Brüggemann; Daniela Berg; Hartwig R Siebner; Anthony E Lang; Peter P Pramstaller; Ferdinand Binkofski; Vladimir S Kostić; Jens Volkmann; Thomas Gasser; Christine Klein
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

8.  ATP13A2 variability in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alexandra I Soto; Sarah J Lincoln; Samia Ben Yahmed; Mounir Kefi; Michael G Heckman; Mary M Hulihan; Hua Chai; Nancy N Diehl; Rim Amouri; Alex Rajput; Deborah C Mash; Dennis W Dickson; Lefkos T Middleton; Rachel A Gibson; Faycal Hentati; Matthew J Farrer
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.

Authors:  Susanne A Schneider; Coro Paisan-Ruiz; Niall P Quinn; Andrew J Lees; Henry Houlden; John Hardy; Kailash P Bhatia
Journal:  Mov Disord       Date:  2010-06-15       Impact factor: 10.338

Review 10.  Neuroimaging features of neurodegeneration with brain iron accumulation.

Authors:  M C Kruer; N Boddaert; S A Schneider; H Houlden; K P Bhatia; A Gregory; J C Anderson; W D Rooney; P Hogarth; S J Hayflick
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

View more
  6 in total

1.  Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea.

Authors:  H K Kim; C S Ki; Y J Kim; M S Lee
Journal:  Clin Neuroradiol       Date:  2017-03-03       Impact factor: 3.649

Review 2.  Neurodegeneration with brain iron accumulation.

Authors:  Susan J Hayflick; Manju A Kurian; Penelope Hogarth
Journal:  Handb Clin Neurol       Date:  2018

Review 3.  Iron metabolism in the CNS: implications for neurodegenerative diseases.

Authors:  Tracey A Rouault
Journal:  Nat Rev Neurosci       Date:  2013-07-03       Impact factor: 34.870

Review 4.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

Review 5.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

Review 6.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.